Author

A. Chrastina

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Organism:rat· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. H. Kadam· 1 shared B. Cederstrom· 1 shared B. Olenyuk· 1 shared C. Yang· 1 shared J. E. Schnitzer· 1 shared J. Koziol· 1 shared J. Rodriguez· 1 shared K. Kandasamy· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. H. Kadam

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting caveolae to pump bispecific antibody to TGF-β into diseased lungs enables ultra-low dose therapeutic efficacy

A. H. Kadam, K. Kandasamy, T. Buss, B. Cederstrom, C. Yang, S. Narayanapillai, J. Rodriguez, M. D. Levin, J. Koziol, B. Olenyuk, Z. Borok, A. Chrastina, J. E. Schnitzer

This paper develops a bispecific antibody that targets caveolae to deliver TGF-β inhibitors specifically to lungs, achieving ultra-low dose therapeutic efficacy in a rat model.

bioRxiv · Sep 12, 2022Bioengineering